(25) |
human prostate cancer tissue |
miR-133b |
Up-regulate |
Exogenous Overexpression of the miR-133b in primary normal prostate firoblasts |
α-SMA, FAP, S100A4 |
|
TGFβ induced HPFs |
|
|
|
|
|
|
IL-6 induced HPFs |
|
|
|
|
|
(40) |
breast cancer tissue |
miR-146b-5p |
down-regulate |
ectopic expression of miR-146b-5p in CAFs |
α-SMA |
|
normal breast tissue |
|
|
inhibition of miR-146b-5p in breast stromal fibroblasts |
|
|
normal breast ajacent to cancer |
|
|
|
|
|
(69) |
mouse pancreat tissue |
miRNA-155 |
Up-regulate |
treated with mouse pancreat normal fibroblasts with pacreatic cancer cell derived microvesicles containing miRNA-155 |
α-SMA and FAP |
(38) |
gastric cancer tissue |
miR-149 |
down-regulate |
ectopic expression of miR-149 in CAFs |
FAP |
|
gastric tissue |
|
|
inhibition of miR-149 in NFs |
|
(66) |
esophageal cancer |
miR-27a/b |
Up-regulate |
Normal fibroblasts from esophagus transfected with pre-miR-27a or pre-miR-27b |
α-SMA and vimentin |
|
normal esophageal tissue |
|
|
|
|
|
(24) |
prostate cancer |
miR-409 |
Up-regulate |
Ectopic expression of miR-409 in normal prostate stromal fibroblasts |
α-SMA |
|
normal prostate tissue |
|
|
|
|
|
(70) |
scirrhous type gastric cancer |
miR-145 |
Up-regulate |
transfected normal fibroblasts with pre-miR-145 and inhibit miR-145 expression in CAFs |
α-SMA |
|
normal gastric tissue |
|
|
|
|
|
(71) |
esophageal cancer |
miR-21 |
Up-regulate |
HGF-1 fibroblasts transfected or inhibited with miR-21 |
S100A4 |
|
HGF-1cell |
|
|
|
|
|
(43) |
MRC5 lung fibroblast cell |
|
Up-regulate |
Stable ectopic expression of miR-21 in immortalised MRC5 fibroblasts |
α-SMA |
|
Primary colonic fibroblasts |
|
|
|
|
(39) |
benign prostatic hyperplasia |
miR-210 |
Up-regulate |
Exogenous Overexpression of the miR-133b in primary normal prostate firoblasts |
α-SMA and collagen I |